Canadian LP TerrAscend Wins New Jersey Medical Cannabis License

Visit the TerrAscend Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.

TerrAscend Controlled Entity Awarded One of Six Permits to Apply For Vertically Integrated Licenses in New Jersey

Permit to apply for cannabis cultivation, processing and retail operations in populous Northern New Jersey region

TORONTO, Dec. 18, 2018 /PRNewswire/ – TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) (“TerrAscend”) is pleased to announce that its majority owned subsidiary, NETA NJ, LLC (the “Applicant”) was awarded a permit to apply for a vertically integrated license in Phillipsburg, NJ. TerrAscend’s minority partners in the Applicant are BWH NJ, LLC and Blue Marble Ventures, LLC and its operations will include cultivation, processing and retail.

We look forward to becoming an integral part of the community and serving the people of Phillipsburg. We are dedicated to improving patient access to quality medicine and are grateful that the New Jersey Department of Health recognized our patient-centric approach.

Patrizia Zita, Principal of Blue Marble Ventures, LLC

Earlier this year, the New Jersey Department of Health (NJ DOH) posted a Request for Applications to operate up to six new vertically integrated Alternative Treatment Centers (ATC). The Department received 146 timely applications submitted by 103 applicants, with several applicants submitting applications to operate ATCs in multiple regions.

We are thrilled to be among the applicants chosen by the NJ DOH. We appreciate the depth and rigor of the application process and look forward to partnering at the state and local level to improve patient access to quality cannabis products and services in Northern New Jersey. With this news, we will begin the build out of our already secured locations in order to meet patients’ needs as soon as possible.

Matthew Johnson, TerrAscend’s President.

About TerrAscend Corp.

TerrAscend is a biopharmaceutical and wellness company committed to quality products, brands and services for the global cannabinoid market. TerrAscend provides support to patients and consumers through its wholly-owned subsidiaries, TerrAscend Canada Inc., a licensed producer of cannabis pursuant to the Cannabis Regulations under the Cannabis Act (Canada) provides medical cannabis to patients through its online medical marketplace Solace Health, and Solace Health Network Inc., a clinical support program and education platform led by healthcare professionals. TerrAscend participates in the legal adult-use market in Canada through direct and indirect supply agreements in several provinces and intends to expand into the US market in states where cannabis has been legalized for therapeutic or adult-use. TerrAscend also has an interest in Ascendant Labs, a cannabis biotechnology and licensing company committed to the continuous improvement of the cannabis plant, which is a strategic joint venture with leading researchers Cistron Corp.

Original Press Release

For fact-based information on TerrAscend, view the company’s sponsored Investor Dashboard.

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter